GlassScriptPhysician profile
Alexandra Navarro
NPI 1598128613
$4,911.25
in general payments reported to CMS, 2019-2025
32 companies · $1,115 in 2025
The $1,115 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $146 · 2021: $660 · 2022: $1,020 · 2023: $959 · 2024: $1,011 · 2025: $1,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,020 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,020.47 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $636.37 | 2021-2025 | |
| Merz North America, INC. | $468.03 | 2021-2025 | Xeomin |
| Janssen Biotech, INC. | $423.55 | 2020-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $300.14 | 2020-2024 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $261.49 | 2021-2025 | Aklief, Nemluvio, Oracea |
| Mayne Pharma Commercial LLC | $254.76 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $251.83 | 2022-2025 | |
| Genzyme Corporation | $237.82 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $233.66 | 2020-2025 | |
| Lilly USA, LLC | $229.90 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Allergan, INC. | $213.24 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $197.53 | 2022-2024 | Sotyktu |
| Biofrontera INC. | $154.84 | 2021-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Hologic Sales and Service, LLC | $142.90 | 2024 | 3dimensions, Thinprep 2000 Processor, Unifi Workspace |
| Almirall LLC | $126.57 | 2021-2025 | Seysara, Klisyri |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $103.97 | 2021 | |
| Pfizer INC. | $95.93 | 2020-2024 | |
| Incyte Corporation | $88.58 | 2022-2025 | Opzelura |
| Amgen INC. | $66.20 | 2021-2025 | Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.19 | 2022-2023 | Spevigo |
| Organon LLC | $50.05 | 2025 | |
| Vyne Pharmaceuticals INC. | $48.58 | 2020-2021 | |
| Ucb, INC. | $47.97 | 2021-2025 | Bimzelx |
| Epi Health, LLC | $44.18 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.11 | 2022-2024 | Jublia |
| Dermavant Sciences, INC. | $30.87 | 2023-2024 | Vtama |
| Leo Pharma INC. | $21.95 | 2020 | |
| Botanix Sb INC | $20.71 | 2025 | Sofdra |
| Arcutis Biotherapeutics, INC. | $17.83 | 2025 | Zoryve |
| Lnhc, INC | $17.68 | 2025 | Zelsuvmi |
| Kyowa Kirin, INC. | $16.16 | 2023 | Poteligeo |
| Verrica Pharmaceuticals INC. | $15.66 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Navarro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.